Изменения структуры печени на фоне длительного приема противоэпилептических препаратов у больных эпилепсией Medline.ru - медико-биологический информационный портал Медлайн.ру

Изменения структуры печени на фоне длительного приема противоэпилептических препаратов у больных эпилепсией

Борисова Е.В., Войтенков В.Б., Тесля О.В., Киссин М.Я., Ларина И.В.

ГУ НИИЭМ РАМН

Резюме

Ключевые слова

(статья в формате PDF. Для просмотра необходим Adobe Acrobat Reader)

открыть статью в

новом окне

Список литературы

1) Sinclair DB, Berg M, Breault R Valproic acid-induced pancreatitis in childhood epilepsy: case series and review. Child Neurol. 2004 Jul;19(7):498-502.

2) . Huang YL, Hong HS, Wang ZW, Kuo TT. Fatal sodium valproate-induced hypersensitivity syndrome with lichenoid dermatitis and fulminant hepatitis.

3). Lackmann GM. Valproic-acid-induced thrombocytopenia and hepatotoxicity: discontinuation of treatment 4) Bin-Nakhi HA, Sadeq S, Pinto RG, Habeeb Y. Anticonvulsant hypersensitivity syndrome: report of 2 cases from Kuwait.

4) Duran-Ferreras E, Mir-Mercader J, Morales-Martinez MD, Martinez-Parra C. Anticonvulsant hypersensitivity syndrome with severe repercussions in the skin and kidneys due to carbamazepine. Rev Neurol. 2004 Jun 16-30;38(12):11.

5) Verrotti A, Trotta D, Morgese G, Chiarelli F. Valproate-induced hyperammonemic encephalopathy. Epilepsia. 2003 Feb;44(2):268.

6) Stefan H. Side effects of anticonvulsants on the peripheral nervous system and vestibuloocular functions. Fortschr Neurol Psychiatr. 1985 Jan;53(1):29-32.

7) DurГn-Ferreras E, Mir-Mercader J, Morales-MartГ-nez MD, MartГ-nez-Parra C. Anticonvulsant hypersensitivity syndrome with severe repercussions in the skin and kidneys due to carbamazepine.

8) Bin-Nakhi HA, Sadeq S, Pinto RG, Habeeb Y. Anticonvulsant hypersensitivity syndrome: report of 2 cases from Kuwait.

9) Muller P, Dubreil P, MahГ? A, Lamaury I, Salzer B, Deloumeaux J, Strobel M. Drug Hypersensitivity Syndrome in a West-Indian population.

10) Kalapos MP. Carbamazepine-provoked hepatotoxicity and possible aetiopathological role of glutathione in the events. Retrospective review of old data and call for new investigation. Adverse Drug Reaction Toxicology Review. 2002; 21(3): 123-41.

11) Lackmann GM. Valproic-acid-induced thrombocytopenia and hepatotoxicity: discontinuation of treatment.

12) Huang YL, Hong HS, Wang ZW, Kuo TT. Fatal sodium valproate-induced hypersensitivity syndrome with lichenoid dermatitis and fulminant hepatitis.

13) Zurh W, Rengeling M, Hackenberg K. Acute liver necrosis caused by valproate. Dtsch Med Wochenschr. 1985 Jun 14;110(24):956-9. 14) AltuntaЕ Y, OztГrk B, Erdem L, GГnes G, Karul S, UГak S, SengГ?l A. Phenytoininduced toxic cholestatic hepatitis in a patient with skin lesions: case report.

15) Bosdure E, Cano A, Roquelaure B, Reynaud R, Boyer M, Viard L, Sarles J. Oxcarbazepine and DRESS syndrome: a paediatric cause of acute liver failure.

16) Veyrac G, Marcade G, Chiffoleau A, Bourin M, Jolliet P. Characteristics of hypersensitivity syndrome to lamotrigine: review of one case reported in the Regional Center of Pharmacovigilance of Nantes.

17) Veyrac G, Marcade G, Chiffoleau A, Bourin M, Jolliet P. Characteristics of hypersensitivity syndrome to lamotrigine: review of one case reported in the Regional Center of Pharmacovigilance of Nantes.

18) Ramos AM, Gayotto LC, Clemente CM, Mello ES, Luz KG, Freitas ML. Reversible vanishing bile duct syndrome induced by carbamazepine. 19) Luef G.J, Waldmann M., Sturm W, Naser A., Trinka E. et al. Valproate therapy and nonalcoholic fatty liver disease. Annals of Neurology. 2004 May; 55(5): 729-32.

20) Клиническое руководство по ультразвуковой диагностике. В V томах. Под. ред. Митькова В.В. Том I, стр. 27-94.